title: Risk stratification of patients with angina pectoris by stress 99mTc-tetrofosmin myocardial perfusion imaging.
abstract: Angina pectoris is a major symptom associated with myocardial ischemia. The aim of this study was to find whether stress myocardial perfusion imaging can independently predict mortality in patients with angina.
  
  
  METHODS
  We studied 455 patients with stable angina pectoris by exercise or dobutamine stress (99m)Tc-tetrofosmin myocardial perfusion tomographic imaging. An abnormal finding was defined as a reversible or fixed perfusion abnormality. The endpoint during follow-up was death from any cause.
  
  
  RESULTS
  Mean age was 60+/-10 y. There were 266 men (58% of the patients). Myocardial perfusion was normal in 137 patients (30%). Perfusion abnormalities were reversible in 167 patients and fixed in 151 patients. During a mean follow-up of 6+/-1.7 y, 93 patients (20%) died. The annual mortality rate was 1.5% in patients with normal perfusion and 4.5% in patients with abnormal perfusion. Patients with a multivessel distribution of perfusion abnormalities had a higher annual death rate than patients with abnormalities in a single-vessel distribution (5.1% vs. 3.7%). In a multivariate analysis model, independent predictors of death were age (risk ratio, 1.05; 95% confidence interval [CI], 1.03-1.08), the male sex (risk ratio, 2.1; CI, 1.3-3.4), diabetes (risk ratio, 2.2; CI, 1.4-3.5), heart failure (risk ratio, 2.7; CI, 1.6-4.5), smoking (risk ratio, 1.7; CI, 1.1-2.6), reversible perfusion abnormalities (risk ratio, 1.9; CI, 1.1-2.8), and fixed perfusion abnormalities (risk ratio, 2; CI, 1.2-3.1).
  
  
  CONCLUSIONS
  Stress 99mTc-tetrofosmin myocardial perfusion imaging provides independent information for predicting mortality in patients with stable angina pectoris. Both reversible and fixed defects are associated with an increased risk of death. The extent of stress perfusion abnormalities is a major determinant of mortality. Patients with normal perfusion have a low mortality rate during long-term follow-up.
authors.affiliation: Thoraxcenter, University Hospital Rotterdam, Rotterdam, The Netherlands. Aelhendy@unmc.edu
authors.forename: Abdou
authors.initials: A
authors.lastname: Elhendy
authors.forename: Arend F L
authors.initials: AF
authors.lastname: Schinkel
authors.forename: Ron T
authors.initials: RT
authors.lastname: van Domburg
authors.forename: Jeroen J
authors.initials: JJ
authors.lastname: Bax
authors.forename: Roelf
authors.initials: R
authors.lastname: Valkema
authors.forename: Aukje
authors.initials: A
authors.lastname: Huurman
authors.forename: Harm H
authors.initials: HH
authors.lastname: Feringa
authors.forename: Don
authors.initials: D
authors.lastname: Poldermans
mesh_terms: D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000000981:diagnostic imaging* / Q000401:mortality / Q000473:pathology*; D003324:Coronary Artery Disease / Q000000981:diagnostic imaging / Q000473:pathology; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009943:Organophosphorus Compounds / Q000494:pharmacology*; D015609:Organotechnetium Compounds / Q000494:pharmacology*; D010477:Perfusion; D011379:Prognosis; D016016:Proportional Hazards Models; D019275:Radiopharmaceuticals / Q000494:pharmacology*; D012306:Risk; D012307:Risk Factors; D013997:Time Factors; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*
chemical_list: D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; C078700:technetium tc-99m tetrofosmin